Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Pharm-country    crawled date : 2022 - 05 - 18    save search

Globus Medical Announces First Surgeries Using Excelsius3D™Intraoperative 3D Imaging System Advances Robotic Navigation Spine Surgery
Published: 2022-05-18 (Crawled : 22:00) - biospace.com/
GMED | $51.27 0.04% 0.0% 900K twitter stocktwits trandingview |
Health Technology
| | O: -1.15% H: 1.46% C: -0.32%

system imaging spine
Seelos Therapeutics Receives a Notice of Allowance in the U.S. for an Additional Patent for SLS-007
Published: 2022-05-18 (Crawled : 17:00) - biospace.com/
SEEL | $0.326 0.09% 0.09% 380K twitter stocktwits trandingview |
Health Technology
| | O: -4.05% H: 7.76% C: -1.5%

sls-007 patent therapeutics
New Data Show TREMFYA® (guselkumab) Binds to Both Inflammatory Cells and Interleukin (IL)-23, Supporting a Hypothesis for a Differentiated Mechanism from Risankizumab
Published: 2022-05-18 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.07% H: 0.0% C: 0.0%

tremfya risankizumab
Legend Biotech to Highlight Continued Progress in the Treatment of Multiple Myeloma With Updated Data From BCMA CAR-T Studies at 2022 ASCO and EHA
Published: 2022-05-18 (Crawled : 14:00) - biospace.com/
LEGN | News | $47.42 0.77% 0.76% 1.8M twitter stocktwits trandingview |
Health Technology
| | O: -2.15% H: 2.71% C: -0.76%

treatment biotech car-t asco
Soligenix to Present at the H.C. Wainwright Global Investment Conference
Published: 2022-05-18 (Crawled : 13:00) - biospace.com/
SNGX | $0.4012 -1.13% -1.15% 450K twitter stocktwits trandingview |
Health Technology
| | O: 3.25% H: 10.64% C: -5.89%

conference
Axsome Therapeutics Announces Publication of Pivotal ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder in The American Journal of Psychiatry
Published: 2022-05-18 (Crawled : 12:00) - biospace.com/
AXSM | $73.055 2.75% 2.68% 700K twitter stocktwits trandingview |
Health Technology
| | O: 4.9% H: 3.4% C: -4.3%

axs-05 trial therapeutics publication phase 2 major depressive disorder
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.